Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: An interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials

John B. Buse, David C. Klonoff, Loretta L. Nielsen, Xuesong Guan, Christopher Bowlus, John H. Holcombe, David G. Maggs, Matthew E. Wintle

Research output: Contribution to journalArticle

225 Scopus citations

Fingerprint Dive into the research topics of 'Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: An interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials'. Together they form a unique fingerprint.

Medicine & Life Sciences